QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Molecular modelling studies on cinnoline-based BTK inhibitors using docking and structure-based 3D-QSAR 期刊论文 SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2018, 卷号: 29, 期号: 11, 页码: 847-873 作者:  Li, R.;  Du, Y.;  Shen, J. 收藏  |  浏览/下载：36/0  |  提交时间：2019/01/08 BTK inhibitors  B-cell malignancies  molecule docking  3D-QSAR  CoMFA  CoMSIA   Discovery of 4,7-Diamino-5-(4-phenoxyphenyl)-6-methylene-pyrinnido[5,4-b]pyrrolizines as Novel Bruton's Tyrosine Kinase Inhibitors 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 61, 期号: 10, 页码: 4608-4627 作者:  Xue, Yu;  Song, Peiran;  Song, Zilan;  Wang, Aoli;  Tong, Linjiang 收藏  |  浏览/下载：32/0  |  提交时间：2019/08/23 Discovery of 4,7-Diamino-5-(4-phenoxyphenyl)-6-methylene-pyrinnido[5,4-b]pyrrolizines as Novel Bruton's Tyrosine Kinase Inhibitors 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 61, 期号: 10, 页码: 4608-4627 作者:  Xue, Yu;  Song, Peiran;  Song, Zilan;  Wang, Aoli;  Tong, Linjiang 收藏  |  浏览/下载：36/0  |  提交时间：2019/01/08 The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 151, 页码: 315-326 作者:  Liang, Chengyuan;  Tian, Danni;  Ren, Xiaodong;  Ding, Shunjun;  Jia, Minyi 收藏  |  浏览/下载：6/0  |  提交时间：2019/11/26 Kinase inhibitor  Irreversible inhibitor  Bruton's tyrosine kinase (BTK)  Reversible covalent inhibitor   Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritis 期刊论文 European Journal of Medicinal Chemistry, 2018, 卷号: Vol.145, 页码: 96-112 作者:  He, L.;  Pei, H.;  Zhang, C.;  Shao, M.;  Li, D. 收藏  |  浏览/下载：5/0  |  提交时间：2019/02/25 Aqueous  solubility  Bioavailability  Btk  Inhibitor  Rheumatoid  arthritis  Selectivity   Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritis 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: Vol.145, 页码: 96-112 作者:  Linhong He;  Heying Pei;  Chufeng Zhang;  Mingfeng Shao;  Dan Li 收藏  |  浏览/下载：13/0  |  提交时间：2019/02/25 Btk  Inhibitor  Selectivity  Bioavailability  Aqueous  solubility  Rheumatoid  arthritis   Development of Bruton's Tyrosine Kinase Inhibitors for Rheumatoid Arthritis 期刊论文 CURRENT MEDICINAL CHEMISTRY, 2018, 卷号: 25, 期号: 42, 页码: 5847-5859 作者:  Lv, Jiahui;  Wu, Jingde;  He, Feng;  Qu, Ying;  Zhang, Qiuqiong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/11 BTK inhibitor  RA  B cell  activity  anti-inflammatory  structure   Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors 期刊论文 ARCHIV DER PHARMAZIE, 2018, 卷号: 351, 期号: 7 作者:  Zhang, Zhen;  Zhang, Daoguang;  Liu, Yang;  Yang, Dezhi;  Ran, Fansheng 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/11 arthritis  Bruton's tyrosine kinase  BTK inhibitor  leukemia  lymphoma   Venetoclax and low-dose cytarabine induced complete remission in a patient with high-risk acute myeloid leukemia: a case report 期刊论文 FRONTIERS OF MEDICINE, 2018, 卷号: 12 - 收藏  |  浏览/下载：0/0  |  提交时间：2020/10/26 BCL-2 INHIBITOR  MIDOSTAURIN  CLASSIFICATION  DECITABINE  MECHANISMS  MUTATIONS  TARGETS  IDH  BTK  venetoclax  cytarabine  AML  leukemia